Esophageal Cancer — High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
Citation(s)
Phase II Study of High-dose (86 Gy)Intensity Modulated Radiotherapy and Concurrent Paclitaxel and Cisplatin in Locoregionally Advanced Esophageal Cancer